Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

VPC-13566

Copy Product Info
🥰Excellent
Catalog No. T29111Cas No. 218464-59-6

VPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the BF3 pocket. VPC-13566 inhibits the growth of various prostate cancer cell lines and reduces the growth of AR-dependent prostate cancer xenograft tumors in mice.

VPC-13566

VPC-13566

Copy Product Info
🥰Excellent
Purity: 99.55%
Catalog No. T29111Cas No. 218464-59-6
VPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the BF3 pocket. VPC-13566 inhibits the growth of various prostate cancer cell lines and reduces the growth of AR-dependent prostate cancer xenograft tumors in mice.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$35In StockIn Stock
5 mg$59In StockIn Stock
10 mg$98In StockIn Stock
25 mg$173In StockIn Stock
50 mg$280In StockIn Stock
100 mg$420In StockIn Stock
1 mL x 10 mM (in DMSO)$70In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.55%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

VPC-13566 AI Summary
VPC-13566 has antagonist activity at the androgen receptor in human LNCaP cells, with an IC50 of 60.0 nM. Additionally, it exhibits a half-life of 0.35 hours in human liver microsomes at a concentration of 2 μM in the presence of NADPH, as measured over a period of 40 minutes..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
VPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the BF3 pocket. VPC-13566 inhibits the growth of various prostate cancer cell lines and reduces the growth of AR-dependent prostate cancer xenograft tumors in mice.
Chemical Properties
Molecular Weight258.32
FormulaC18H14N2
Cas No.218464-59-6
SmilesCC1=C2C(C(=CN2)C3=NC4=C(C=C3)C=CC=C4)=CC=C1
Relative Density.1.225 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 65 mg/mL (251.63 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.8712 mL19.3558 mL38.7117 mL193.5584 mL
5 mM0.7742 mL3.8712 mL7.7423 mL38.7117 mL
10 mM0.3871 mL1.9356 mL3.8712 mL19.3558 mL
20 mM0.1936 mL0.9678 mL1.9356 mL9.6779 mL
50 mM0.0774 mL0.3871 mL0.7742 mL3.8712 mL
100 mM0.0387 mL0.1936 mL0.3871 mL1.9356 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy VPC-13566 | purchase VPC-13566 | VPC-13566 cost | order VPC-13566 | VPC-13566 chemical structure | VPC-13566 formula | VPC-13566 molecular weight